Program
Monday, June 24
Opening Remarks:
10:00
Tadashi YAMAMOTO, Director, RIKEN IMS
Session I:

INFLAMMATION, RESOLUTION, AND REPAIR

Chairs: H. CHEROUTRE and H. UENO

10:10

I-1

Shigekazu NAGATA, Osaka University (Japan)
Phospholipid Flippase and Scramblase

10:40

I-2

Mauro PERRETTI, Queen Mary University of London (UK)
Resolution Pharmacology: harnessing pro-resolving GPCRs to control chronic diseases

11:10

Coffee Break

11:30

I-3

Hilde CHEROUTRE, RIKEN IMS (Japan) / La Jolla Institute for Immunology (USA)The Cd8 locus controls CD4 T helper cell Plasticity

12:00

I-4

Paul MARTIN, University of Bristol (UK)Imaging inflammation and it consequences in wound repair and cancer

12:30

Lunch

13:40

I-5

Hideki UENO, Icahn School of Medicine at Mount Sinai (USA)Why is the efficacy of seasonal influenza vaccine limited? Blame on Tfh1.

14:10

I-6

Sachiko MIYAKE, Juntendo University (Japan)
Unique activation status of CNS innate immunity in systemic inflammatory conditions

Short Talk 1 Asuka TERASHIMA, The University of Tokyo (Japan)
14:40
Interaction between bone and immune cells in inflammation
Session II:

TOOLBOX FOR BIOMEDICAL SCIENCES

15:00 II-1

Atsushi MIYAWAKI, RIKEN CBS / RIKEN RAP (Japan)
Luminescence imaging

15:30

Coffee Break

15:50 II-2

Mihai G NETEA, Radboud University Medical Center (Netherlands)
Trained immunity: Metabolic and Epigenetic Reprogramming in Myeloid Cells

16:20 II-3

Judi ALLEN, University of Manchester (UK)
Learning from Helminths: Macrophages, Type 2 immunity & Tissue Repair

16:50 II-4

Aki MINODA, RIKEN IMS (Japan)
Capturing immunosenescence of the innate immune system at the single cell resolution

Chairs: J. ALLEN and A. MINODA

Short Talk 2 Keiichiro SUZUKI, RIKEN IMS (Japan)
17:20
IgA regulate composition and metabolic function of gut microbiome by modulating bacteria
gene expression
17:35

End of the dayTuesday, June 25
Session III:BRAIN- IMMUNITY AXIS

Chairs: J. GOMMERMAN and K. SUZUKI

9:30 III-1 Martin KERSCHENSTEINER, Ludwig-Maximilians University Munich (Germany)
In vivo regulation of phagocyte phenotypes and effector function in the inflamed CNS
10:00 III-2 Kazuhiro SUZUKI, Osaka University (Japan)
Anatomical and functional connections of adrenergic nerves with lymphoidmicroarchitectures
10:30

Coffee Break

10:50 III-3 Jennifer GOMMERMAN, University of Toronto (Canada)
Recirculating Intestinal IgA-producing cells Regulate Inflammation via IL10
11:20

III-4 Masaaki MURAKAMI, Hokkaido University (Japan)
Regional neural activations establish gateways for autoreative T cells to enter the CNS

Short Talk 3 Saya MORIYAMA, National Institute of Infectious Diseases (Japan)
11:50
Neuronal regulation of group 2 innate lymphoid cell responses and type 2 inflammation
Publisher Talk
12:05

Alejo CHORNY, Journal of Experimental Medicine, Rockefeller University (USA)
Scientific Publishing: What, How and Why?”

12:35

LunchSession IV:

HUMAN IMMUNODEFICIENCY

14:10 IV -1

Alain FISCHER, Collège de France/ Assistance Publique-Hôpitaux de Paris/ Institut Imagine (France)
Lymphoid organogenesis in humans

Chairs: T. MORIO and F. SALLUSTO

14:40 IV -2 Tomohiro MORIO, Tokyo Medical and Dental University (Japan)
Primary immunodeficiency disorders caused by a mutation in IKAROS family gene
15:10 IV -3

Federica SALLUSTO, ETH Zurich / IRB-USI Bellinzona (Switzerland)
Human T cell repertoires in health and disease

15:40Coffee Break

16:10 IV -4

Stuart TANGYE, Garvan Institute of Medical Research / UNSW Sydney (Australia)
Molecular regulation of human immunity – lessons from primary immunodeficiencies

16:40 IV -5 Cheng-Lung KU, Chang Gung University (Taiwan)
Anti-interferon-γ autoantibodies: from molecular to the infectious disease.
Short Talk 4 Daisuke SUGIURA, Tokushima University (Japan)
17:10
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell
response
Closing Remarks:
17:25
Sidonia FAGARASAN, Chair, Program Committee
18:00

Social Gathering